Prospects for IL-16 in the treatment of AIDS. - Wikidata - wikimedia - TriplyDB

Prospects for IL-16 in the treatment of AIDS.

Prospects for IL-16 in the treatment of AIDS.

http://www.wikidata.org/entity/Q34451973

about

Host factors influencing susceptibility to HIV infection and AIDS progression.

P2860

Q35995936-A0A657E5-E59C-48D8-88D2-D93FD378EF3E

P2860

Prospects for IL-16 in the treatment of AIDS.

http://www.wikidata.org/entity/Q34451973

description

2001 nî lūn-bûn

@nan

2001 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Prospects for IL-16 in the treatment of AIDS.

@ast

Prospects for IL-16 in the treatment of AIDS.

@en

Prospects for IL-16 in the treatment of AIDS.

@nl

type

label

Prospects for IL-16 in the treatment of AIDS.

@ast

Prospects for IL-16 in the treatment of AIDS.

@en

Prospects for IL-16 in the treatment of AIDS.

@nl

prefLabel

Prospects for IL-16 in the treatment of AIDS.

@ast

Prospects for IL-16 in the treatment of AIDS.

@en

Prospects for IL-16 in the treatment of AIDS.

@nl

P1433

Q34451973-AC7CCB1A-E334-4AFB-B392-FCD3E6C9477C

P1476

Q34451973-1C7A7A0B-1F48-49E1-9A2F-22390711849E

P2093

Q34451973-2BF55F53-50F9-4BC5-9656-B3F41DCD0C85

Q34451973-B677EB9F-127E-4DD1-9B22-DA8652F577E6

P2860

Q34451973-07466213-6FD4-44F3-8EBB-1A0C938FE164

Q34451973-26AE2503-6848-4BAE-AC55-3B92987BEA3D

Q34451973-2866BE61-6A8A-44CE-AD97-ADDA1B0EC7E3

Q34451973-2BB7C443-3742-45F2-BF0A-27090BB8C142

Q34451973-2D3D8C2C-42FB-410A-88F5-29679E1D2099

Q34451973-393516E9-C001-4C9B-ACEF-928C742CD3E8

Q34451973-3A495BD9-4236-42AF-A5ED-88F405A6B0ED

Q34451973-4B0C0711-C694-4704-94E8-ED626F2AB704

Q34451973-4F1504FF-ED93-43AC-AC6F-20C68C708041

Q34451973-5D41CFFB-8AA9-4543-9F9F-914F391BFC5F

P304

Q34451973-1FE1D2DC-1CAB-4727-99E6-5A11CA93A8F2

P31

Q34451973-D929BC5F-89CB-4FD5-8A5A-7F57E01986CD

P356

Q34451973-47EB42C3-2DFA-4822-B471-9A2EAD74CA9D

P407

Q34451973-8D79B1DA-F58A-4E8E-963B-165D38DA7094

P433

Q34451973-F30DC77D-C0C7-4E39-A991-EEC0A41A63FF

P478

Q34451973-248E0EE2-9199-4C46-BB2B-EBBBE9E47E17

P577

Q34451973-B77D703E-5431-484F-ACB1-C7CB94BCEB8D

P698

Q34451973-C8698E76-6A33-40BB-AEC8-6D9420E49A63

P356

14712598.1.3.425

P1433

Expert Opinion on Biological Therapy

P1476

Prospects for IL-16 in the treatment of AIDS.

@en

P2093

Cruikshank WW

http://www.w3.org/2001/XMLSchema#string

Kornfeld H

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor

Dimeric association and segmental variability in the structure of human CD4

Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA

Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression

CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration

Structure of interleukin 16 resembles a PDZ domain with an occluded peptide binding site

Identification of a CD4 domain required for interleukin-16 binding and lymphocyte activation

The CD4-associated tyrosine kinase p56lck is required for lymphocyte chemoattractant factor-induced T lymphocyte migration

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.

CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine.

P304

425-432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.1.3.425

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2001-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11727516

http://www.w3.org/2001/XMLSchema#string